Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. File:Novartis-Logo.svg - Wikipedia

   en.wikipedia.org/wiki/File:Novartis-Logo.svg

   File:Novartis-Logo.svg. Size of this PNG preview of this SVG file: 512 × 84 pixels. Other resolutions: 320 × 53 pixels | 640 × 105 pixels | 1,024 × 168 pixels | 1,280 × 210 pixels | 2,560 × 420 pixels. Original file ‎ (SVG file, nominally 512 × 84 pixels, file size: 2 KB) This is a file from the Wikimedia Commons.

3. Novartis - Wikipedia

   en.wikipedia.org/wiki/Novartis

   Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4][5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...

4. Chiron Corporation - Wikipedia

   en.wikipedia.org/wiki/Chiron_Corporation

   vaccines, blood testing. Revenue. $1.921 billion (2005) Number of employees. 5,400 (2005) Website. www.chiron.com. Chiron Corporation (/ ˈkaɪrɒn / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006.

5. Novartis Gene Therapies - Wikipedia

   en.wikipedia.org/wiki/Novartis_Gene_Therapies

   Novartis Gene Therapies, until 2020 known as AveXis, is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in Dallas , Texas , United States in 2012 by John Carbona after reorganizing a company called BioLife Cell Bank founded by David Genecov and John Harkey.

6. Vasant Narasimhan - Wikipedia

   en.wikipedia.org/wiki/Vasant_Narasimhan

   Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018. [5] He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for ...

7. Novartis CEO criticizes US, EU efforts to curb drug company ...

   www.aol.com/finance/novartis-ceo-criticizes-us...

   Novartis (NVS) CEO Vas Narasimhan has been vocal about the pressure the drug industry is facing both in the U.S. and in Europe, but he argues the Inflation Reduction Act and Europe's proposed ...